|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
1 months to Jan 31, 2024
|
FY2022
1 months to Jan 31, 2023
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flow From Operating Activities | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Amortization expense | |||||
| Change in fair value of business acquisition liabilities | |||||
| Deferred income taxes | |||||
| Business exit related impairments | |||||
| VMS Trade name and other asset impairments | |||||
| VMS Trade Name | |||||
| Flawless Trade Name | |||||
| Total vMS Trade name and other asset impairments | |||||
| Loss on sale of vitamin business | |||||
| Equity in net earnings of affiliates | |||||
| Distributions from unconsolidated affiliates | |||||
| Non-cash compensation expense | |||||
| Asset impairment charge and other asset write-offs | |||||
| Other | |||||
| Subtotal | |||||
| Change in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Income taxes payable | |||||
| Other operating assets and liabilities, net | |||||
| Change in Working Capital | |||||
| Net Cash Provided By Operating Activities | |||||
| Cash Flow From Investing Activities | |||||
| Additions to property, plant and equipment | |||||
| Acquisitions | |||||
| Proceeds from Sale of Passport | |||||
| Proceeds from Sale of Vitamin Business | |||||
| Other | |||||
| Net Cash Used In Investing Activities | |||||
| Cash Flow From Financing Activities | |||||
| Long-term debt borrowings | |||||
| Repayments of long-term debt | |||||
| Short-term debt (repayments), net of borrowings | |||||
| Proceeds from stock options exercised | |||||
| Payment of cash dividends | |||||
| Purchase of treasury stock | |||||
| Deferred financing and other | |||||
| Payment of business acquisition liability | |||||
| Other | |||||
| Net Cash Used In Financing Activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net Change In Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
| Cash paid during the year for: | |||||
| Interest (net of amounts capitalized) | |||||
| Income taxes | |||||
| Supplemental disclosure of non-cash investing activities: | |||||
| Property, plant and equipment expenditures included in Accounts Payable | |||||
Loading...